Latest Insider Transactions at U.S. Stem Cell, Inc. (USRM)
This section provides a real-time view of insider transactions for U.S. Stem Cell, Inc. (USRM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of U.S. Stem Cell, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of U.S. Stem Cell, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 25
2022
|
Gregory Knutson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500,000
+7.89%
|
-
|
|
Mar 18
2022
|
Gregory Knutson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000,000
+48.38%
|
$0
$0.01 P/Share
|
|
Apr 02
2021
|
Gregory Knutson Director |
BUY
Other acquisition or disposition
|
Indirect |
187,575
+0.53%
|
$0
$0.05 P/Share
|
|
Mar 23
2021
|
William P Murphy Jr Director |
BUY
Grant, award, or other acquisition
|
Indirect |
7,518,797
+44.57%
|
$0
$0.03 P/Share
|
|
Oct 05
2020
|
Gregory Knutson Director |
BUY
Other acquisition or disposition
|
Indirect |
2,035,820
+5.45%
|
-
|
|
Apr 01
2020
|
Gregory Knutson Director |
BUY
Other acquisition or disposition
|
Indirect |
1,445,647
+4.29%
|
$0
$0.01 P/Share
|